tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INTS Stock Latest News

Intensity Therapeutics Pauses Enrollment in INVINCIBLE-4 Study
Company AnnouncementsIntensity Therapeutics Pauses Enrollment in INVINCIBLE-4 Study
12d ago
8K
INTS
Intensity Therapeutics pauses new patient enrollment in INVINCIBLE-4 trial
PremiumThe Fly
Intensity Therapeutics pauses new patient enrollment in INVINCIBLE-4 trial
12d ago
INTS
Intensity Therapeutics price target lowered to $1.50 from $4 at Benchmark
PremiumThe Fly
Intensity Therapeutics price target lowered to $1.50 from $4 at Benchmark
1M ago
INTS
Intensity Therapeutics Reports Reduced Losses and Clinical Progress
PremiumCompany Announcements
Intensity Therapeutics Reports Reduced Losses and Clinical Progress
1M ago
INTS
Intensity Therapeutics Amends Bylaws for Quorum Change
PremiumCompany Announcements
Intensity Therapeutics Amends Bylaws for Quorum Change
1M ago
8K
INTS
Intensity Therapeutics upgraded to Buy from Hold at Brookline
PremiumThe FlyIntensity Therapeutics upgraded to Buy from Hold at Brookline
1M ago
INTS
Intensity Therapeutics regains Nasdaq compliance
Premium
The Fly
Intensity Therapeutics regains Nasdaq compliance
1M ago
INTS
Intensity Therapeutics Raises $6.6 Million in July Offering
Premium
Company Announcements
Intensity Therapeutics Raises $6.6 Million in July Offering
2M ago
8K
INTS
Intensity Therapeutics raises $6.6M from ATM stock sales in July
PremiumThe Fly
Intensity Therapeutics raises $6.6M from ATM stock sales in July
2M ago
INTS
Intensity Therapeutics initiated with a Buy at ThinkEquity
PremiumThe Fly
Intensity Therapeutics initiated with a Buy at ThinkEquity
2M ago
INTS
Intensity Therapeutics Holds Annual Stockholders’ Meeting
PremiumCompany Announcements
Intensity Therapeutics Holds Annual Stockholders’ Meeting
2M ago
8K
INTS
Intensity Therapeutics: INT230-6 achieved 100% complete response rate in MPNST
PremiumThe Fly
Intensity Therapeutics: INT230-6 achieved 100% complete response rate in MPNST
3M ago
INTS
Intensity Therapeutics Completes $1.9 Million Stock Offering
PremiumCompany AnnouncementsIntensity Therapeutics Completes $1.9 Million Stock Offering
3M ago
8K
INTS
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
Premium
Market News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories
3M ago
BA
KO
Intensity Therapeutics 6.675M share Spot Secondary priced at 30c
Premium
The Fly
Intensity Therapeutics 6.675M share Spot Secondary priced at 30c
3M ago
INTS
Intensity Therapeutics announces common stock offering, no amount given
PremiumThe Fly
Intensity Therapeutics announces common stock offering, no amount given
3M ago
INTS
Intensity Therapeutics reports data from Invincible-4 study
PremiumThe Fly
Intensity Therapeutics reports data from Invincible-4 study
3M ago
INTS
Intensity Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
Intensity Therapeutics Faces Nasdaq Delisting Notice
4M ago
8K
INTS
Intensity Therapeutics price target lowered to $3.50 from $8.50 at Alliance Global Partners
PremiumThe Fly
Intensity Therapeutics price target lowered to $3.50 from $8.50 at Alliance Global Partners
4M ago
INTS
Intensity Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany AnnouncementsIntensity Therapeutics Faces Nasdaq Non-Compliance Notice
4M ago
8K
INTS
Intensity Therapeutics downgraded to Hold from Buy at Brookline
Premium
The Fly
Intensity Therapeutics downgraded to Hold from Buy at Brookline
4M ago
INTS
Intensity Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Intensity Therapeutics Reports Q1 2025 Financial Results
4M ago
INTS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >